Implementation of drug-eluting stents for the treatment of femoropopliteal disease provides significant cost-to-system savings in a single-state outpatient simulation

OBJECTIVES: Initial data on drug-eluting stents (DES) shows that they may increase the durability of endovascular treatment of superficial femoral artery disease compared with traditional bare-metal stents (BMS). Observed decreased target lesion revascularization (TLR) rates have potential for cost...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Vasc Surg
Hlavní autoři: Sridharan, Natalie Domenick, Liang, Nathan, Robinson, Darve, Avgerinos, Efthymios, Tzeng, Edith, Makaroun, Michel S., Chaer, Rabih A., Eslami, Mohammad H.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6394222/
https://ncbi.nlm.nih.gov/pubmed/29779962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvs.2018.02.040
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky